Eye, ear, nose, and throat

Educational resources

20210203 Beovu TA card front cover image

NICE Technology Appraisal 672: ▼Brolucizumab for treating wet age-related macular degeneration

Commissioned by Novartis Pharmaceuticals UK Ltd

The printing of this Guidelines summary card has been commissioned by Novartis Pharmaceuticals UK Ltd. Information intended for UK healthcare professionals only.
Click here for Prescribing information and Adverse Event Reporting.

MLR ID 103903
Date of preparation: February 2021